Increasing Amounts of Senior Citizens Seek Hemp Alternatives
For individuals past the age of 65, Hemp based alternatives are a growing trend that touts benefits of pain relief, little to no possible side effects and natural/safe origins. Seniors see the value in products such as these, especially from reputable sources and brands. Even media platforms such as AARP, Forbes, and Reader’s Digest highlight the benefits of seniors adding a CBD product to their daily routine.
The Many Benefits of CBD Products
Individuals over the age of sixty-five may begin experiencing symptoms that prove to be permanent on some occasions. Pain and inflammation, anxiety stress, and sleeping disorders, even digestive disorders can occur later in life.
Inflammatory Pain Relief
Many Doctors and Researchers alike have an interest in the possibilities that CBD could offer. Some preliminary research suggests that Cannabidiol may help minimize arthritis pain. CBD relieved arthritis pain and inflammation in animal studies. However, effects may vary in human models so more trials are necessary. In fact, 2016 analysis of human trials for Rheumatoid Arthritis, Osteoarthritis and Fibromyalgia found that CBD improved pain and sleep.
Additionally, CBD has been reported to cause modulation of TNF , IL-1, and IFN-γ production by human peripheral blood mononuclear cells. This is promising considering that high levels of these cytokines can cause inflammation and damage cells and tissues. Cannabidiol has also been shown to suppress chemokine production by a human B cell line. These potentially anti-inflammatory properties of CBD, the lack of psychotropic effects and lack of toxicity, prompted the testing of the potential of CBD. Researchers theorized CBD as a therapeutic agent in collagen-induced arthritis which acts as a murine model for Rheumatoid Arthritis. CBD was administered after onset of clinical symptoms. In both models of arthritis, the treatment blocked progression of the disease.
With these results, certain Doctors are extremely hopeful about this option for countless inflammatory conditions. For example, Daniel Clauw, MD, an expert in chronic pain, acknowledges CBD’s potential benefits and recommends it to some of his patients. He states “Nearly all potential side effects of cannabinoids are from THC, not CBD.”
Anxiety and Sleep Aid
Countless studies suggest Cannabidiol acts as an effective anxiolytic, (used to reduce anxiety). CBD has a broad pharmacological profile, including interactions with several receptors known to regulate fear and anxiety-related behaviors. Preclinical evidence demonstrates CBD’s effectiveness in producing the desired effect of reducing anxiety behaviors relevant to multiple disorders. Additional evidence suggests Cannabichromene (CBC) as well as Cannabidivarin act as effective regulators in regards to anxiety and mood disorders. Currently, GW Pharmaceuticals researches and develops Cannabichromene and Cannabidivarin as effective treatments for a wide variety of such disorders.
Cannabidiol (CBD) offers promising results in trials aimed to exhibit its effects on sleep cycles. In a study among individuals with insomnia, results suggested that administration of 160 mg/day of CBD increased total sleep time and decreased the frequency of arousals during the night. Interestingly, effects of CBD on sleep seem to differ based on concentration of dose. Lower mg doses displayed a sort of stimulating effect.
Additionally, recent work in animal models has focused on the effect of CBD on sleep quality and sleep–wake cycles. Researchers found an increase in total percentage of sleep in rats after administration of mid-range and high-dose CBD injections as compared to placebo. The effects on REM varied by dosage such that high-dose CBD increased REM sleep latency on the day of administration and midrange dose CBD decreased REM sleep latency the day after administration. In addition, they found that CBD blocked anxiety-induced REM sleep suppression.
The Endocannabinoid System regulates various functions in the body. It has been shown to play a key role in the development of Irritable Bowel Disorder. In the Gastrointestinal System, CB1 and CB2 receptors are found in all layers of intestinal sections. Numerous studies conducted with mouse models have demonstrated a relationship between the Endocannabinoid System and regulation of gut inflammation. Recent experimental data supports an important role for natural Cannabinoids in Gastrointestinal Diseases (Schicho and Storr, 2012). In fact, Cannabis has been proposed to treat Gastrointestinal conditions that range from infections and inflammation to disorders of abdominal pain. Data gathered in trials demonstrated that Cannabinoids may hinder the release of a wide class of pro-inflammatory mediators (molecules that promote inflammation). Even Cannabichromene exhibited the ability to normalize intestinal motility in the inflamed gut.
In summary, Cannabinoids may be a safe alternative to current treatments. More studies, in clinical settings are necessary to prove the viability of this option however. Several individuals have reported their use of Cannabinoids, largely CBD, in the management of their Inflammatory Digestive Conditions. Popularly, sufferers have been using CBD or Cannabinoid Infused foods and oils to target these conditions. It is likely that the CBD market will expand to include all sorts of products aiming at relieving a multitude of symptoms. This will likely cause a demand for previously mentioned trials and testing.
CBD Products Bypass Pharmaceuticals with Serious Side Effects
When considering options, CBD (Cannabidiol) has grown increasingly popular for those seeking analgesic effects without the harmful addictive compounds often found in pharmaceutical drugs. CBD, amongst other Cannabinoids, offers promising results when reducing inflammation and oxidative stress. CBD also has the advantage of not having psychotropic side effects. Studies on models of human diseases support the idea that CBD attenuates inflammation far beyond its antioxidant properties. For example, by targeting inflammation-related intracellular signaling events.
A separate 2012 study published in the European Journal of Pharmacology concluded that Cannabidiol has anti-inflammatory effects on human models. These conclusions support the findings of earlier studies, like a 2006 investigation of Cannabidiol that found it could effectively act as an oral therapeutic agent for chronic inflammatory and neuropathic pain. Research sponsored by the US Government outlines the possibility of CBD as a treatment for a wide range of conditions including but not limited to arthritis, diabetes, alcoholism, Multiple Sclerosis, chronic pain, schizophrenia, PTSD, depression, antibiotic-resistant infections, epilepsy, and other neurological disorders. CBD demonstrates neuroprotective and neurogenic effects, and researchers currently investigate the anti-cancer properties worldwide.
In 2015, a review of studies focused on the connection of CBD and addiction found that the molecule affected neurotransmitters involved in addiction. Other studies with Cannabidiol showed beneficial effects for tobacco dependence. This evidence indicates that CBD could effectively manage pain previously managed with Prescription Opioids.
Seniors Celebrate New Alternatives
The CBD trend lacks exclusivity and more individuals turn to these alternatives than ever before. Adults 65 and over can especially benefit from all the actions these compounds have to offer. Individuals experiencing inflammation, pain, digestive and sleeping disorders can all find aid with these products. Check out our shop for products aimed at providing you with relief.